| Literature DB >> 28423341 |
Tak W Mak1, Melanie Grusdat2, Gordon S Duncan3, Catherine Dostert2, Yannic Nonnenmacher4, Maureen Cox3, Carole Binsfeld2, Zhenyue Hao5, Anne Brüstle6, Momoe Itsumi7, Christian Jäger8, Ying Chen9, Olaf Pinkenburg10, Bärbel Camara10, Markus Ollert11, Carsten Bindslev-Jensen12, Vasilis Vasiliou9, Chiara Gorrini3, Philipp A Lang13, Michael Lohoff10, Isaac S Harris14, Karsten Hiller15, Dirk Brenner16.
Abstract
Activated T cells produce reactive oxygen species (ROS), which trigger the antioxidative glutathione (GSH) response necessary to buffer rising ROS and prevent cellular damage. We report that GSH is essential for T cell effector functions through its regulation of metabolic activity. Conditional gene targeting of the catalytic subunit of glutamate cysteine ligase (Gclc) blocked GSH production specifically in murine T cells. Gclc-deficient T cells initially underwent normal activation but could not meet their increased energy and biosynthetic requirements. GSH deficiency compromised the activation of mammalian target of rapamycin-1 (mTOR) and expression of NFAT and Myc transcription factors, abrogating the energy utilization and Myc-dependent metabolic reprogramming that allows activated T cells to switch to glycolysis and glutaminolysis. In vivo, T-cell-specific ablation of murine Gclc prevented autoimmune disease but blocked antiviral defense. The antioxidative GSH pathway thus plays an unexpected role in metabolic integration and reprogramming during inflammatory T cell responses.Entities:
Keywords: GSH; Gclc; Myc; NFAT; ROS; T cells; glutathione; glycolysis; mTOR; metabolic reprogramming; metabolism; reactive oxygen species
Mesh:
Substances:
Year: 2017 PMID: 28423341 DOI: 10.1016/j.immuni.2017.03.019
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745